CEUFAST COURSE

Neonatal Glucose Management

Contact Hour(s): 1.5 Contact Hours, including 1.5 Advanced Pharmacology HoursAuthor:Alyssa King, DNP, APRN, CPNP-PC, PMHNP-BC, PMH-C, CLC, CNEKrystle Maynard, DNP, RN, SANE-AThis peer-reviewed course is applicable for the following profe...

Course Summary

Contact Hour(s): 

1.5 Contact Hours, including 1.5 Advanced Pharmacology Hours

Author:

Alyssa King, DNP, APRN, CPNP-PC, PMHNP-BC, PMH-C, CLC, CNE

Krystle Maynard, DNP, RN, SANE-A

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN)

Accreditations: 

The American Nurses Credentialing Center (ANCC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353

Course Description:

This course discusses the definitions, pathophysiology, recognition, prevention, nursing care, and nursing management for both neonatal hypoglycemia and neonatal hyperglycemia.

Outcomes:

≥ 92% of participants will know how to provide evidence-based care for glucose management in the neonate.

Objectives:

After completing this continuing education course, the participant will be able to:

  1. Determine the importance of glucose management in the neonate.
  2. Describe the process of glucose metabolism and homeostasis in the neonate.
  3. Identify the changes that occur in the transition from intrauterine to extrauterine life for the neonate, as they pertain to glucose metabolism.
  4. Explain the signs and symptoms, nursing care, and nursing management for neonatal hypoglycemia.
  5. Examine the signs and symptoms, nursing care, and nursing management for neonatal hyperglycemia.


Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.